• Founded in 2000
  • Employees: 110

Description :

Symphogen is engaged in developing recombinant antibody mixtures, a new class of biopharmaceuticals for the treatment or prophylaxis of serious human diseases.

Headquarters :

Elektrovej Building 375
2800 Lyngby

Related Posts

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.